Published in Infect Immun on March 01, 2000
Tracking insertion mutants within libraries by deep sequencing and a genome-wide screen for Haemophilus genes required in the lung. Proc Natl Acad Sci U S A (2009) 3.35
Epithelial antimicrobial peptides in host defense against infection. Respir Res (2000) 2.40
The simple sequence contingency loci of Haemophilus influenzae and Neisseria meningitidis. J Clin Invest (2001) 2.04
Relationships of nontypeable Haemophilus influenzae strains to hemolytic and nonhemolytic Haemophilus haemolyticus strains. J Clin Microbiol (2007) 2.04
Human beta-defensins 2 and 3 demonstrate strain-selective activity against oral microorganisms. J Clin Microbiol (2004) 1.91
Pathogenic neisseriae: surface modulation, pathogenesis and infection control. Nat Rev Microbiol (2009) 1.87
Phosphorylcholine decreases early inflammation and promotes the establishment of stable biofilm communities of nontypeable Haemophilus influenzae strain 86-028NP in a chinchilla model of otitis media. Infect Immun (2006) 1.71
Analysis of nontypeable haemophilus influenzae phase-variable genes during experimental human nasopharyngeal colonization. J Infect Dis (2013) 1.64
Nontypeable Haemophilus influenzae gene expression induced in vivo in a chinchilla model of otitis media. Infect Immun (2003) 1.63
Susceptibility of nontypeable Haemophilus influenzae to human beta-defensins is influenced by lipooligosaccharide acylation. Infect Immun (2002) 1.40
Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37. Infect Immun (2008) 1.39
A mutation in the sap operon attenuates survival of nontypeable Haemophilus influenzae in a chinchilla model of otitis media. Infect Immun (2005) 1.37
Expression of C-reactive protein in the human respiratory tract. Infect Immun (2001) 1.31
Nontypeable Haemophilus influenzae clearance by alveolar macrophages is impaired by exposure to cigarette smoke. Infect Immun (2009) 1.30
Phosphorylcholine expression by nontypeable Haemophilus influenzae correlates with maturation of biofilm communities in vitro and in vivo. J Bacteriol (2007) 1.27
Role of complement in defense of the middle ear revealed by restoring the virulence of nontypeable Haemophilus influenzae siaB mutants. Infect Immun (2006) 1.25
Lipooligosaccharides containing phosphorylcholine delay pulmonary clearance of nontypeable Haemophilus influenzae. Infect Immun (2008) 1.20
Biofilm growth increases phosphorylcholine content and decreases potency of nontypeable Haemophilus influenzae endotoxins. Infect Immun (2006) 1.10
Decoration of Pasteurella multocida lipopolysaccharide with phosphocholine is important for virulence. J Bacteriol (2007) 1.09
Retracted Human cathelicidin LL-37 enhance the antibiofilm effect of EGCG on Streptococcus mutans. BMC Oral Health (2016) 1.06
Non-typeable Haemophilus influenzae invasion and persistence in the human respiratory tract. Front Cell Infect Microbiol (2011) 1.05
Defensins and other antimicrobial peptides at the ocular surface. Ocul Surf (2004) 1.00
Phosphorylcholine allows for evasion of bactericidal antibody by Haemophilus influenzae. PLoS Pathog (2012) 0.99
Sap transporter mediated import and subsequent degradation of antimicrobial peptides in Haemophilus. PLoS Pathog (2011) 0.96
Microbial modulation of host immunity with the small molecule phosphorylcholine. Infect Immun (2012) 0.96
Relative contributions of lipooligosaccharide inner and outer core modifications to nontypeable Haemophilus influenzae pathogenesis. Infect Immun (2013) 0.96
ArcA-regulated glycosyltransferase lic2B promotes complement evasion and pathogenesis of nontypeable Haemophilus influenzae. Infect Immun (2011) 0.96
Proteomic expression profiling of Haemophilus influenzae grown in pooled human sputum from adults with chronic obstructive pulmonary disease reveal antioxidant and stress responses. BMC Microbiol (2010) 0.94
Prevalence of genetic differences in phosphorylcholine expression between nontypeable Haemophilus influenzae and Haemophilus haemolyticus. BMC Microbiol (2010) 0.93
A chaotic pore model of polypeptide antibiotic action. Biophys J (2007) 0.92
The licC gene of Streptococcus pneumoniae encodes a CTP:phosphocholine cytidylyltransferase. J Bacteriol (2001) 0.92
Expression of factor H binding protein of meningococcus responds to oxygen limitation through a dedicated FNR-regulated promoter. J Bacteriol (2009) 0.91
Cationic antimicrobial peptide resistance mechanisms of streptococcal pathogens. Biochim Biophys Acta (2015) 0.91
Interaction of CAP18-derived peptides with membranes made from endotoxins or phospholipids. Biophys J (2001) 0.91
Human antibodies specific for the high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae mediate opsonophagocytic activity. Infect Immun (2003) 0.91
A member of the cathelicidin family of antimicrobial peptides is produced in the upper airway of the chinchilla and its mRNA expression is altered by common viral and bacterial co-pathogens of otitis media. Mol Immunol (2006) 0.89
Antibodies specific for the high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae are opsonophagocytic for both homologous and heterologous strains. Clin Vaccine Immunol (2006) 0.87
Variation in Streptococcus pneumoniae susceptibility to human antimicrobial peptides may mediate intraspecific competition. Proc Biol Sci (2012) 0.87
SapF-mediated heme-iron utilization enhances persistence and coordinates biofilm architecture of Haemophilus. Front Cell Infect Microbiol (2012) 0.86
Duplicate copies of lic1 direct the addition of multiple phosphocholine residues in the lipopolysaccharide of Haemophilus influenzae. Infect Immun (2007) 0.85
Bacterial Evasion of Host Antimicrobial Peptide Defenses. Microbiol Spectr (2016) 0.82
Genome-scale approaches to identify genes essential for Haemophilus influenzae pathogenesis. Front Cell Infect Microbiol (2012) 0.82
Antibodies to the HMW1/HMW2 and Hia adhesins of nontypeable haemophilus influenzae mediate broad-based opsonophagocytic killing of homologous and heterologous strains. Clin Vaccine Immunol (2014) 0.82
Anti-Legionella dumoffii activity of Galleria mellonella defensin and apolipophorin III. Int J Mol Sci (2012) 0.81
Absence of membrane phosphatidylcholine does not affect virulence and stress tolerance phenotypes in the opportunistic pathogen Pseudomonas aeruginosa. PLoS One (2012) 0.81
Antiviral Activity of the Human Cathelicidin, LL-37, and Derived Peptides on Seasonal and Pandemic Influenza A Viruses. PLoS One (2015) 0.80
Functional genomics of pathogenic bacteria. Philos Trans R Soc Lond B Biol Sci (2002) 0.80
Host Antimicrobial Peptides in Bacterial Homeostasis and Pathogenesis of Disease. Antibiotics (Basel) (2014) 0.78
Structurally identical capsular polysaccharide expressed by intact group B streptococcus versus Streptococcus pneumoniae elicits distinct murine polysaccharide-specific IgG responses in vivo. J Immunol (2012) 0.78
Pneumococcal Haemophilus influenzae protein D conjugate vaccine induces antibodies that inhibit glycerophosphodiester phosphodiesterase activity of protein D. Infect Immun (2008) 0.78
Comparative Analyses of the Lipooligosaccharides from Nontypeable Haemophilus influenzae and Haemophilus haemolyticus Show Differences in Sialic Acid and Phosphorylcholine Modifications. Infect Immun (2016) 0.76
Vitamin D3 Supplementation and Antibiotic Consumption - Results from a Prospective, Observational Study at an Immune-Deficiency Unit in Sweden. PLoS One (2016) 0.75
Potential Use of Antimicrobial Peptides as Vaginal Spermicides/Microbicides. Pharmaceuticals (Basel) (2016) 0.75
Neisseria cinerea expresses a functional factor H binding protein which is recognised by immune responses elicited by meningococcal vaccines. Infect Immun (2017) 0.75
Choline-containing teichoic acid as a structural component of pneumococcal cell wall and its role in sensitivity to lysis by an autolytic enzyme. J Biol Chem (1970) 6.06
Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell (1997) 5.99
Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect Immun (1994) 4.90
Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science (1997) 4.81
Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides. Cell (1998) 4.42
Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J Infect Dis (1998) 4.12
Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. Proc Natl Acad Sci U S A (1991) 3.98
Production of beta-defensins by human airway epithelia. Proc Natl Acad Sci U S A (1998) 3.85
The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci U S A (1998) 3.83
The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem (1997) 3.82
The molecular mechanism of phase variation of H. influenzae lipopolysaccharide. Cell (1989) 3.60
Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest (1998) 3.51
Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob Agents Chemother (1998) 3.45
Antibacterial peptides: key components needed in immunity. Cell (1991) 3.22
Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem (1998) 2.91
FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci U S A (1995) 2.89
Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J Exp Med (1998) 2.65
Elemental composition of human airway surface fluid in healthy and diseased airways. Am Rev Respir Dis (1993) 2.40
The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun (1999) 2.35
Decoration of lipopolysaccharide with phosphorylcholine: a phase-variable characteristic of Haemophilus influenzae. Infect Immun (1997) 2.27
The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood (1997) 2.16
Innate antimicrobial activity of nasal secretions. Infect Immun (1999) 2.13
Genetic and physical map of the chromosome of Hemophilus influenzae. J Mol Biol (1969) 2.11
The role of a repetitive DNA motif (5'-CAAT-3') in the variable expression of the Haemophilus influenzae lipopolysaccharide epitope alpha Gal(1-4)beta Gal. Mol Microbiol (1993) 1.98
Adaptation of Haemophilus influenzae to acquired and innate humoral immunity based on phase variation of lipopolysaccharide. Mol Microbiol (1998) 1.96
Interaction of the mammalian antibacterial peptide cecropin P1 with phospholipid vesicles. Biochemistry (1995) 1.77
The position of phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae affects binding and sensitivity to C-reactive protein-mediated killing. Mol Microbiol (2000) 1.70
The concentration-dependent membrane activity of cecropin A. Biochemistry (1997) 1.29
Detection of the phosphorylcholine epitope in streptococci, Haemophilus and pathogenic Neisseriae by immunoblotting. Microb Pathog (1997) 1.17
Structural analysis of the lipopolysaccharide oligosaccharide epitopes expressed by a capsule-deficient strain of Haemophilus influenzae Rd. Eur J Biochem (1999) 1.13
An unusual polar lipid from the cell membrane of Mycoplasma fermentans. Eur J Biochem (1995) 1.10
Antiphosphorylcholine antibody levels are elevated in humans with periodontal diseases. Infect Immun (1999) 1.06
Naturally occurring antibodies to phosphocholine as a potential index of antibody responsiveness to polysaccharides. J Infect Dis (1987) 1.03
Structural studies of the cell-envelope oligosaccharide from the lipopolysaccharide of Haemophilus influenzae strain RM.118-28. Eur J Biochem (1997) 0.94
High anti-phosphorylcholine antibody levels and mortality associated with pneumonia. Scand J Infect Dis (1990) 0.90
The oligosaccharide of Haemophilus influenzae. Microb Pathog (1992) 0.83
Interaction of the 47-residue antibacterial peptide seminalplasmin and its 13-residue fragment which has antibacterial and hemolytic activities with model membranes. Biochemistry (1993) 0.80
Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci U S A (1994) 8.13
Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell (1997) 5.99
Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J Virol (1996) 5.94
Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol (1995) 5.67
Severe impairments of social interaction and associated abnormalities in children: epidemiology and classification. J Autism Dev Disord (1979) 5.40
ran1+ controls the transition from mitotic division to meiosis in fission yeast. Curr Genet (1985) 5.18
Recombinant adeno-associated virus for muscle directed gene therapy. Nat Med (1997) 4.87
Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol Microbiol (1997) 4.78
MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity (1994) 4.65
Gene therapy vectors based on adeno-associated virus type 1. J Virol (1999) 4.63
Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat Genet (1994) 4.33
Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae. J Infect Dis (1998) 4.12
Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nat Genet (1992) 4.12
Studies on alcaptonuria: 2. Investigations on a case of human alcaptonuria. Biochem J (1947) 4.03
Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus. Proc Natl Acad Sci U S A (1997) 3.84
The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci U S A (1998) 3.83
Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell (1990) 3.70
Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat Genet (1994) 3.56
Outer membrane protein A of Escherichia coli contributes to invasion of brain microvascular endothelial cells. Infect Immun (1996) 3.53
Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest (1998) 3.51
Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci U S A (1994) 3.38
Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur J Immunol (2001) 3.34
Identification of sequences in a yeast histone promoter involved in periodic transcription. Cell (1986) 3.22
Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. J Clin Invest (1998) 3.17
Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J Virol (1998) 3.14
Natural variation in light sensitivity of Arabidopsis. Nat Genet (2001) 2.97
Screening for refractive errors at age 1 year: a pilot study. Br J Ophthalmol (1979) 2.94
Inhibitory and bactericidal effects of hydrogen peroxide production by Streptococcus pneumoniae on other inhabitants of the upper respiratory tract. Infect Immun (2000) 2.91
Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model. Hum Mol Genet (2001) 2.88
Replication-defective vector based on a chimpanzee adenovirus. J Virol (2001) 2.86
Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Mol Ther (2001) 2.83
Screening for visual defects in preschoolchildren. Br J Ophthalmol (1986) 2.82
Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy. J Thromb Haemost (2006) 2.81
Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum Gene Ther (2001) 2.69
Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses. Nat Genet (1993) 2.67
Non-typeable Haemophilus influenzae adhere to and invade human bronchial epithelial cells via an interaction of lipooligosaccharide with the PAF receptor. Mol Microbiol (2000) 2.65
A first attempt to prevent amblyopia and squint by spectacle correction of abnormal refractions from age 1 year. Br J Ophthalmol (1985) 2.65
Gene therapy: adenovirus vectors. Curr Opin Genet Dev (1993) 2.61
A possible nucleotide-binding domain in the tertiary fold of phosphoribosyltransferases. J Biol Chem (1983) 2.60
Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature (1994) 2.57
Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat Med (1995) 2.55
[Principles and practice of mass screening for disease]. Bol Oficina Sanit Panam (1968) 2.54
Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Mol Ther (2001) 2.53
A model system for in vivo gene transfer into the central nervous system using an adenoviral vector. Nat Genet (1993) 2.53
Human beta-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J (2001) 2.52
Relationship between colonial morphology and adherence of Streptococcus pneumoniae. Infect Immun (1995) 2.50
Anteroapical stunning and left ventricular outflow tract obstruction. Mayo Clin Proc (2001) 2.48
Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study. Hum Gene Ther (1993) 2.48
The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment. Proc Natl Acad Sci U S A (1993) 2.48
Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J Virol (2001) 2.46
Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res (2001) 2.45
Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther (1996) 2.43
Prediction of amblyopia and squint by means of refraction at age 1 year. Br J Ophthalmol (1986) 2.35
Recombinant adenovirus deleted of all viral genes for gene therapy of cystic fibrosis. Virology (1996) 2.35
A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology (1996) 2.35
Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc Natl Acad Sci U S A (1995) 2.33
CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science (1996) 2.21
Relationship between cell surface carbohydrates and intrastrain variation on opsonophagocytosis of Streptococcus pneumoniae. Infect Immun (1999) 2.20
Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver. Mol Ther (2001) 2.19
A possible role for kinase-associated protein phosphatase in the Arabidopsis CLAVATA1 signaling pathway. Proc Natl Acad Sci U S A (1997) 2.19
The Silent Gallstone: A Ten to Twenty Year Follow-up Study of 112 Cases. Ann Surg (1948) 2.18
Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J Virol (1996) 2.12
Cell transplantation in liver-directed gene therapy. Cell Transplant (1994) 2.12
Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits. Science (1991) 2.11
Current surgical management of congenital diaphragmatic hernia: a report from the Congenital Diaphragmatic Hernia Study Group. J Pediatr Surg (1998) 2.09
Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector. Nat Med (1999) 2.07
Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study. Hum Gene Ther (1993) 2.07
Expression of alpha v beta 5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway. J Virol (1995) 2.05
Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in vivo. Hum Gene Ther (2000) 1.97
Adeno-associated virus as a vector for liver-directed gene therapy. J Virol (1998) 1.94
The innate immune system in cystic fibrosis lung disease. J Clin Invest (1999) 1.93
Benign small bowel tumor. Ann Surg (1975) 1.92
Cathelicidins--a family of multifunctional antimicrobial peptides. Cell Mol Life Sci (2003) 1.89
Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma. Ann Thorac Surg (1994) 1.89
Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc Natl Acad Sci U S A (1999) 1.89
Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect Immun (1999) 1.87
Microarray-based identification of htrA, a Streptococcus pneumoniae gene that is regulated by the CiaRH two-component system and contributes to nasopharyngeal colonization. Infect Immun (2002) 1.87
Nosocomial Pseudomonas pickettii bacteremias traced to narcotic tampering. A case for selective drug screening of health care personnel. JAMA (1991) 1.86
Recruitment of wild-type and recombinant adeno-associated virus into adenovirus replication centers. J Virol (1996) 1.86
Inhalation therapy in asthma: nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children. J Pediatr (1999) 1.85
Communicating with the dying. J Med Ethics (1975) 1.84
Primary malignancies of the small bowel: a report of 96 cases and review of the literature. Ann Surg (1974) 1.82
Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria. J Immunol (1997) 1.80
Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat Biotechnol (2001) 1.80
Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo. J Immunol (1995) 1.75
The role of macrophages in mice infected with murine cytomegalovirus. J Gen Virol (1978) 1.71
In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J Biol Chem (1994) 1.71
Molecular basis of defective anion transport in L cells expressing recombinant forms of CFTR. Hum Mol Genet (1993) 1.71
Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype. Am J Med Genet (2000) 1.71
Targeting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo. J Biol Chem (1989) 1.70
Expression of the cystic fibrosis gene in adult human lung. J Clin Invest (1994) 1.70
Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a. Hum Gene Ther (1994) 1.70
Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. J Virol (1996) 1.70
The position of phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae affects binding and sensitivity to C-reactive protein-mediated killing. Mol Microbiol (2000) 1.70
Binding of the non-typeable Haemophilus influenzae lipooligosaccharide to the PAF receptor initiates host cell signalling. Cell Microbiol (2001) 1.68
High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus. Hum Gene Ther (1998) 1.68
Transcriptional repression by Msx-1 does not require homeodomain DNA-binding sites. Mol Cell Biol (1995) 1.67
Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men. J Urol (1999) 1.67
Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes. J Virol (2004) 1.66
Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. Role in the acute inflammatory response. J Biol Chem (1990) 1.65